>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • MLI +9.6%, FLXS +6.2%, MMM +4.9%, SAP +3.5%, RLI +2.8%, ZION +2.8%, DGX +2.1%, RTX +2%, HSTM +1.9%, PM +1.7%, BKU +1.6%, PNR +1.5%, PHM +1.4%, ARE +1.2%, WTFC +1.1%, DHR +1.1%, BOKF +1%, CATY +0.9%, ONB +0.9%, PEBO +0.8%, GM +0.8%, LMT +0.5%
Other news:
  • IRTC +16.5% (FDA grants clearance for 510(k) submission related to design changes made to the Zio AT device)
  • IMUX +11.9% (announces a positive outcome of the non-binding, interim futility analysis of its phase 3 ENSURE program, investigating lead asset, nuclear receptor related 1 activator, vidofludimus calcium, for the treatment of relapsing multiple sclerosis)
  • MOLN +5.2% (Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics)
  • CAKE +3.7% (activist urging to consider breakup, according to WSJ)
  • WT +3.7% (WTAM agreed to resolve the matter by consenting to the entry of an Order by the SEC)
  • RDHL +3.1% (collaboration with a leading U.S. academic medical center to develop Opaganib as a countermeasure against phosgene inhalation injury)
  • MGNX +2.6% (MacroGenics and TerSera Therapeutics LLC have entered into an agreement in which TerSera will acquire global rights to MARGENZA)
  • CLLS +2.5% (to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress)
  • ANNX +2.5% (Presents Phase 2 Vision Preservation Data with ANX007)
  • FUFU +2.5% (has entered into a definitive agreement to acquire a majority stake in an 80-megawatt Bitcoin mining facility in Ethiopia)
  • NRIX +2% (presentations announced to summarize new data)
  • OMC +1.8% (files mixed shelf)
  • DAR +1.6% (publishes collagen peptides study)
  • CRC +1.5% (Kern County approves of conditional use permit for CTV I carbon capture)
  • ESEA +1.1% (new 3-year time charter contracts)
  • CRDL +1% (plans to expand the MAVERIC clinical development program and advance CardiolRx into a late-stage clinical trial to evaluate the impact of CardiolRx)
Analyst comments:
  • FSLR +1.9% (upgraded to Buy from Neutral at Citigroup)
  • FLR +1.5% (upgraded to Buy from Neutral at Citigroup)
  • AEG +0.9% (upgraded to Buy from Neutral at UBS)
  • PCTY +0.9% (upgraded to Buy from Hold at Jefferies)